GGrantIndex
Sort

326,823 grants matching clinical trial

A vaccine design to induce protective B and T cell immunity against hepatitis C virus

$2,498,468
Steven Foung · Stanford University · U19 · FY2022 · AI

Targeted Therapies in Melanoma

$2,498,463
Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA

The Pediatric Brain Tumor Consortium (PBTC)

$2,498,325
James M Boyett · St. Jude Children'S Research Hospital · U01 · FY2007 · CA

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH

$2,498,155
Robert Stanley Sherwin · Yale University · UL1 · FY2010 · RR

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults

$2,498,125
Joshua D Lee · New York University School Of Medicine · U01 · FY2024 · DA

Statistical Methods for Integrative Genomics in Cancer

$2,497,918
William James Gauderman · University Of Southern California · P01 · FY2025 · CA

MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM

$2,497,744
Rebecca Schnall · Columbia University Health Sciences · UH3 · FY2024 · AI

University of Puerto Rico Clinical Trials Unit

$2,497,560
Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2011 · AI

Systemic Autoimmunity

$2,497,545
Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR

Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards

$2,497,158
Dorothy K Hatsukami · University Of Minnesota · P01 · FY2020 · CA

Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces

$2,497,111
Robert A Britton · Baylor College Of Medicine · U19 · FY2024 · AI

Epidemiology of Diabetes Interventions and Complications Data Coordinating Center

$2,496,965
John M Lachin · George Washington University · U01 · FY2014 · DK

CLINICAL TRIAL - REGENERATIVE MEDICIINE, PAIN, SENSORY SYSTEM

$2,496,854
Duke University · · FY2012 · Department of the Army

Epigenetic, Protein, and Cellular Biomarkers of Beta Cell Function in T1D

$2,496,787
Kevan C Herold · Yale University · UC4 · FY2014 · DK

SPORE in Ovarian Cancer

$2,496,726
Ie-Ming Shih · Johns Hopkins University · P50 · FY2024 · CA

Role of microbiome in cancer and inflammation

$2,496,470
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

FUNCTION BIRN

$2,496,261
Steven G Potkin · University Of California-Irvine · U24 · FY2010 · RR

FUNCTION BIRN

$2,496,260
Steven G Potkin · University Of California-Irvine · U24 · FY2010 · RR

Lymphoma Specialized Program of Research Excellence (SPORE)

$2,496,123
George J Weiner · University Of Iowa · P50 · FY2007 · CA

Targeted Therapies in Melanoma

$2,496,009
Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA

Relative Efficacy of Single-, Bi-, and Tri-Hormonal Closed-Loop Control Systems

$2,495,873
Ananda Basu · University Of Virginia · DP3 · FY2015 · DK

Improving the Clinical Effectiveness and Understanding of the Biophysical Basis

$2,495,754
Thomas F Delaney · Massachusetts General Hospital · U19 · FY2015 · CA

Protein-mediated membrane remodeling

$2,495,466
Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD

Wisconsin NCI Community Oncology Research Program (WiNCORP)

$2,495,248
Adedayo A Onitilo · Marshfield Clinic Research Foundation · UG1 · FY2015 · CA

Growth Factor Imaging and Photoimmunotherapy

$2,495,095
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA